Anaplasmosis control and diagnosis in South Africa.

Anaplasmosis is widespread in South Africa with more than 99% of the total cattle population at risk. Five tick species have been experimentally shown to be capable of transmitting Anaplasma in South Africa. Mechanical transmission through blood contaminated instruments and biting flies also occurs. Vaccination against Anaplasma marginale by administration of an Anaplasma centrale live-blood vaccine has been practiced in this country since 1912. Although generally a mild pathogen, Anaplasma centrale can cause severe clinical reactions following vaccination and also does not afford complete protection against all A. marginale isolates. Anaplasmosis vaccine is routinely available in a deep-frozen form and approximately 220,000 doses of vaccine are sold per annum. Microscopic examination of stained thin blood smears is still the most reliable and cost effective method of confirming a clinical diagnosis of anaplasmosis. Several diagnostic tests, such as the complement fixation tests, card agglutination test, and enzyme-linked immunosorbent assay (ELISA) have been developed to identify carrier cattle. A competitive inhibition ELISA test, based on antibody binding to a recombinant MSP-5 protein conserved among Anaplasma species, is routinely used at this laboratory.

The absence of clinical disease in cattle in communal grazing areas where farmers are changing from an intensive dipping programme to one of endemic stability to tick-borne diseases.

A two-year field study was conducted in four communal grazing areas in South Africa. Sera were collected from young cattle (6-18 months old) in these areas during the winters of 1991 to 1993. The sera were tested for antibodies to Babesia bovis, Babesia bigemina, Anaplasma marginale and Cowdria ruminantium. In two of the four areas, treatment with acaricide was erratic and dependent on the discretion of individual owners. In these areas the drought of 1992 had a major impact on tick burdens and there were changes in the seroprevalence to tick-borne diseases. In the other two areas there was a reduction in the intensity of acaricide application and this was associated with an increase in seropositivity to the tick-borne diseases. Increases in the prevalence of seropositivity and the presence of endemic instability, as calculated from inoculation rates, were not accompanied by outbreaks of clinical disease. Possible reasons for this are discussed.